
Please try another search
Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China. It offers human insulin API and injections; insulin glargine API and injections; insulin aspart API and injections; liraglutide injections; zhennaoning capsules; and diabetes-related medical devices. The company also provides insulin pen and needle injection system, blood sugar monitoring system, and online and offline patient management system. In addition, it offers chemical drugs, such as repaglinide and empagliflozin tablets. Further, the company offers building materials, including plastic steel windows and profiles; and engages in the real estate industry. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is headquartered in Tonghua, China.
Name | Age | Since | Title |
---|---|---|---|
Fu Bo Cao | 54 | 2014 | Supervisor |
Qingxia He | 45 | 2020 | Employee Representative Supervisor |
Junye Wang | 59 | 2014 | Chairman of the Supervisory Board |
Li Xu | 57 | 2022 | Independent Director |
Wei Wang | 41 | 2020 | Director |
Jianchun Zhen | 34 | 2023 | Director |
Jiahong Li | 36 | 2020 | Chairman of the Board |
Dai Xu | 57 | 2022 | Independent Director |
Yan Bi | 58 | 2015 | Independent Director |
Wenhai Zhang | 51 | 2020 | Deputy GM & Director |
Guodong Zhang | 49 | 2020 | Deputy GM & Director |
Chun Sheng Leng | 51 | 2014 | Vice Chairman & GM |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review